Target intelligence / Profile preview

Ankyrin repeat domain-containing protein 34B (ANKRD34B)

Target
ANKRD34B
Molecular classification
Other (Ankyrin repeat domain-containing protein), Protein binding scaffold (contains ankyrin repeat motifs)
01

Overview

Ankyrin repeat domain-containing protein 34B (ANKRD34B) is a protein encoded by the human ANKRD34B gene, with the canonical UniProt ID A5PLL1. It is part of a broad family of proteins defined by the presence of ankyrin repeat motifs, which serve as common protein–protein interaction scaffolds in diverse cellular processes. The ankyrin repeat is a structural motif that mediates specific binding surfaces for molecular recognition, but ANKRD34B itself does not have a well-established, unique molecular function or enzyme activity. Bioinformatic predictions suggest its localization to the cytoplasm and nucleus, perhaps associated with structures like pi-bodies. There is a single, weak disease association (neonatal candidiasis), but the evidence is limited and does not support a therapeutic role. ANKRD34B is not currently the subject of approved or investigational drugs, nor is it used as a diagnostic or predictive biomarker. Its role, if any, in disease remains to be thoroughly characterized. - ANKRD34B is a non-enzymatic, non-receptor protein characterized by ankyrin repeat domains that likely function in general protein scaffolding and interactions, with no established direct therapeutic relevance. - There is no evidence for it being a current or emerging therapeutic target, no known small molecule modulators, and no notable safety concerns or biomarker utility.

Other names
Ankyrin repeat domain-containing protein 34BANKRD34BDendritic cell progenitor protein of 58 kDa
02

Mechanism of action

Not applicable; this is not presently a therapeutic target, and there are no drugs known to act via this protein

03

Biological functions

Potential roles predicted in protein–protein interaction and molecular scaffoldingNo well-characterized specific cellular or physiological functions described in the literature as of now
04

Disease associations

Weak and indirect genetic association reported with Neonatal candidiasisThere is no strong or direct evidence linking this molecule to major disease pathways in therapeutically targeted contexts
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on Ankyrin repeat domain-containing protein 34B (ANKRD34B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain-containing protein 34B (ANKRD34B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call